Short answer
Sana Biotechnology, Inc. (SANA) filed an 8-K current report with the SEC on May 15, 2026 reporting Item 8.01 (Other Events). $69.0 million net proceeds raised through sales of 21,607,878 common shares.
Sana Biotechnology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $69.0 million net proceeds raised through sales of 21,607,878 common shares
- Equity issuance creates dilution for existing shareholders
- Capital supplied under amended sales agreement with TD Securities as sales agent
- Funding increases liquidity for Sana’s ongoing operations and biotechnology programs
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sana Biotechnology, Inc. 8-K filings
Get the next SANA 8-K as it lands
Follow SANA for push alerts, or ask the research agent what this filing means.